Abstract
Coagulation abnormalities and bleeding disorders are frequently encountered in patients undergoing invasive procedures. These are of particular importance in the pain management setting where even small amounts of excessive bleeding can result in devastating complications. It is imperative that physicians treating those patients understand the basic concepts of coagulation and be able to identify and manage the common bleeding disorders. This article provides a brief overview of the coagulation system and describes the use of appropriate screening tests and management strategies to limit bleeding in pain management procedures.
Similar content being viewed by others
References and Recommended Reading
Rappaport SI: Preoperative hemostatic evaluation: which tests if any? Blood 1983, 61:229–233.
Close HL, Kryzer TC, Nowlin JH, Alving BM: Hemostatic assessment of patients before tonsillectomy: a prospective study. Otolaryngol Head Neck Surg 1994, 111:733–738.
Lind SE: The bleeding time does not predict surgical bleeding. Blood 1991, 77:2547–2551.
Rogers RPC, Levin J: A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990, 16:1–20.
Landefeld CS, Beyth RJ: Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 1993, 95:315–328.
Horlocker TT, Wedel DJ: Spinal and epidural blockade and perioperative low molecular weight heparin: smooth sailing in the Titanic. Anesth Analg 1998, 86:1153–1156.
Vandermeulen EP, Van Aken H, Vermylen J: Anticoagulants and spinal-epidural anesthesia. Anesth Analg 1994, 79:1165–1177.
Horlocker TT, Heit JA: Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management. Anesth Analg 1997, 85:874.
Sadler JE: A revised classification of von Willebrand disease. Thromb Haemost 1994, 71:520–525.
Weigert AL, Schafer AI: Uremic bleeding: pathogenesis and therapy. Am J Med Sci 1998, 316:94–104.
Peterson P, Hayes TE, Arkin CF, et al.: The preoperative bleeding time test lacks clinical benefit: college of American Pathologists’ and American Society of Clinical Pathologists position article. Arch Surg 1998, 133:134–139. Discusses the limitations of bleeding time as a routine preoperative test.
Manucci PM: Hemostatic drugs [review]. New Engl J Med 1998, 339:245–253. In-depth review of common hemostatic agents available and appropriate use.
DeLoughery TG: Management of bleeding with uremia and liver disease. Curr Opin Hematol 1999, 6:329–333. Pathophysiology of bleeding in uremia and liver failure and excellent recommendation in managing these patients.
Geourge JN, Woolf SH, Raskob GE, et al.: Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996, 88:3–40.
Hedner U: Recombinant activated factor VII as a universal hemostatic agent. Blood Coagul Fibrinolysis 1998, (suppl 1):S147–152. Discusses the rationale and reviews current data on the use of this agent.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cobos, E., Cruz, JC. & Day, M. Etiology and management of coagulation abnormalities in the pain management patient. Current Review of Pain 4, 413–419 (2000). https://doi.org/10.1007/s11916-000-0026-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11916-000-0026-2